Autologous Hematopoietic Stem Cell-Based Gene Therapy

All categories
DBCAT005722Pharmacologic class

Genetic therapy consisting of autologous hematopoietic stem cells (HSCs). A DrugBank category of 5 drugs. 5 of them are approved.

Part of
Autologous Cultured Cell
Drugs

What you can answer from here — as of August 23, 2022

5DrugsEach linked to its full drug card
Listed above
5Drug targetsEvery drug–target pair in the class, with bond type
Sign in
9Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
1Route of administrationHow the drugs in this class are given
Sign in

Which targets do Autologous Hematopoietic Stem Cell-Based Gene Therapy share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In